Learn More
Cayman Chemical EOPt18 028 018 2-d11 100UG

Supplier: Cayman Chemical 9004339100 UG

A TNNI3K inhibitor and sorafenib derivative (IC50 10 nM) selective for TNNI3K over VEGFR2 p38a and B-RAF (IC50s 400 800 and >2000 nM respectively) reduces superoxide levels in isolated left ventricular tissues and infarct size in a mouse model of myocardial ischemia-reperfusion injury induced by LAD coronary artery occlusion at 2.75 mg/kg
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.